Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course.
暂无分享,去创建一个
L. Medeiros | C. Bueso-Ramos | R. Lai | A. Glassman | D. Weber | A. Mansoor | L. Medeiros | R. Alexanian | D. Jones | K. Hayes | Dan M. Jones | R. Lai | C. Bueso‐Ramos
[1] J. Dierlamm. Genetic abnormalities in marginal zone B-cell lymphoma. , 2003, Haematologica.
[2] L. Pease,et al. Clonal evolution in Waldenstrom macroglobulinemia highlights functional role of B-cell receptor. , 2001, Blood.
[3] B. Grosbois,et al. patients with the description of a new scoring system and its validation on 253 other patients. , 2000, Blood.
[4] G. Morgan,et al. Waldenström's macroglobulinaemia: Laboratory diagnosis and treatment , 2000, Hematological oncology.
[5] G. Morgan,et al. Clinicopathological correlates of IgM paraproteinemias. , 2000, Clinical lymphoma.
[6] G Flandrin,et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] G Flandrin,et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] R. Siebert,et al. Clinicopathogenetic significance of chromosomal abnormalities in patients with blastic peripheral B-cell lymphoma. Kiel-Wien-Lymphoma Study Group. , 1999, Blood.
[9] P. Wiernik,et al. Multiple karyotypic aberrations in a polymorphous variant of Waldenström macroglobulinemia. , 1999, Cancer genetics and cytogenetics.
[10] O. Haas,et al. Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma. , 1998, Blood.
[11] A case of t(8;14) with total and partial trisomy 3 in Waldenstrom macroglobulinemia. , 1998, Cancer genetics and cytogenetics.
[12] C. Preudhomme,et al. THE CLINICAL SIGNIFICANCE OF MUTATIONS OF THE P52 TUMOUR SUPPRESSOR GENE IN HAEMATOLOGICAL MALIGNANCIES , 1997, British journal of haematology.
[13] R. Siebert,et al. Frequent deletions of 6q23–24 in B‐cell non‐Hodgkin's lymphomas detected by fluorescence in situ hybridization , 1997, Genes, chromosomes & cancer.
[14] R. Dalla‐Favera,et al. The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. , 1996, Blood.
[15] B. Nathwani,et al. Numerical cytogenetic abnormalities of chromosomes 3, 7, and 12 in marginal zone B-cell lymphomas. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[16] H. Nawata,et al. [Primary macroglobulinemia with t(11;18) (q21;q21)]. , 1996, [Rinsho ketsueki] The Japanese journal of clinical hematology.
[17] L. Foroni,et al. Deletion of chromosome 13 (band ql4) but not trisomy 12 is a clonal event in B‐chronic lymphocytic leukaemia (CLL) , 1995, British journal of haematology.
[18] Y. Kwong,et al. Concomitant partial tetrasomy 3q and trisomy 18 in Waldenström macroglobulinemia. , 1995, Cancer genetics and cytogenetics.
[19] P. Isaacson,et al. Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue. , 1995, Blood.
[20] N. Weiss,et al. Incidence of Waldenström's macroglobulinemia. , 1993, Blood.
[21] K Offit,et al. t(9;14)(p13;q32) denotes a subset of low-grade non-Hodgkin's lymphoma with plasmacytoid differentiation. , 1992, Blood.
[22] F. Caradonna,et al. Chromosomal abnormalities in Waldenström's macroglobulinemia. , 1992, Cancer genetics and cytogenetics.
[23] F. Mitelman. ISCN 1991 : guidelines for cancer cytogenetics : supplement to An international system for human cytogenetic nomenclature : recommendations of the Standing Committee on Human Cytogenetic Nomenclature, Subcommittee on Cancer Cytogenetics , 1992 .
[24] P. Wiernik,et al. Neoplastic Diseases of the Blood , 1991 .
[25] M. Ladanyi,et al. Cytogenetic analysis of 434 consecutively ascertained specimens of non‐Hodgkin's lymphoma: Correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment , 1991, Genes, chromosomes & cancer.
[26] L. Stuppia,et al. Chromosome changes in 19 patients with Waldenström's macroglobulinemia. , 1987, Cancer genetics and cytogenetics.
[27] R. Kyle,et al. The spectrum of IgM monoclonal gammopathy in 430 cases. , 1987, Mayo Clinic proceedings.
[28] C. S. San Román,et al. Clonal abnormalities in patients with Waldenström's macroglobulinemia with special reference to a Burkitt-type t(8;14). , 1985, Cancer genetics and cytogenetics.
[29] G. Hoffmann-Fezer,et al. Bone marrow histology in Waldenström's macroglobulinaemia. Clinical relevance of subtype recognition. , 2009, Scandinavian journal of haematology.
[30] K. Takatsuki,et al. Cytogenetic studies and clinical aspects of patients with plasma cell leukemia and leukemic macroglobulinemia. , 1983, Cancer research.
[31] E. Henderson,et al. Clonal chromosome abnormalities in patients with Waldenström's and CLL-associated macroglobulinemia: significance of trisomy 12. , 1983, Blood.
[32] O. Olivares,et al. [Waldenström's macroglobulinemia]. , 1966, Revista medica de Chile.